Asthma is a heterogeneous chronic respiratory disease that impacts nearly 10% of the
population worldwide. While cellular senescence is a normal physiological process, the …

Abstract Purpose of Review To assess the effects of tezepelumab on quality of life (QoL) in
patients with moderate-to-severe, uncontrolled asthma. Recent Findings Tezepelumab …

Over 20 million adults and 6 million children in the United States (US) have asthma, a
chronic respiratory disease characterized by airway inflammation, bronchoconstriction, and …

Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps -
Otolaryngologic Clinics of North America Skip to Main Content Skip to Main Menu …

Thymic stromal lymphopoietin (TSLP) is a pleiotropic cytokine that has emerged as a critical
player in the development and progression of allergy and asthma. It is primarily produced by …

Introduction Biologics targeting type 2 inflammation have revolutionized the way we treat
patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe …

PURPOSE OF THE REVIEW: Asthma is a major global disease affecting adults and children,
which can lead to hospitalization and death due to breathing difficulties. Although targeted …

重度哮喘是哮喘患者致死和致残的主要因素, 可造成巨大的社会和经济压力. 近年来,
随着对哮喘病理机制的深入了解, 生物靶向治疗逐渐成为重度哮喘治疗的新选择 …

Inflammatory diseases represent a diverse group of disorders stemming from an overactive
immune response, affecting various organs and tissues and manifesting a spectrum of …

Background Asthma is a spectrum of chronic conditions that exhibit airway inflammation and
hyperreactivity. 1 Severe asthma affects approximately 5% to 10% of individuals living with …